-
1
-
-
29744463847
-
Longitudinal study of survival and causes of death in patients with thalassemia major in Greece
-
V. Ladis G. Chouliaras H. Berdousi E. Kanavakis C. Kattamis 2005 Longitudinal study of survival and causes of death in patients with thalassemia major in Greece Ann N Y Acad Sci 1054 445 450
-
(2005)
Ann N Y Acad Sci
, vol.1054
, pp. 445-450
-
-
Ladis, V.1
Chouliaras, G.2
Berdousi, H.3
Kanavakis, E.4
Kattamis, C.5
-
4
-
-
33644874106
-
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassemia
-
Roberts DJ, Rees D, Howard J, Hyde C, Alderson P, Brunskill S. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassemia. Cochrane Database Syst Rev 2005 19: CD004450.
-
(2005)
Cochrane Database Syst Rev
, vol.19
-
-
Roberts, D.J.1
Rees, D.2
Howard, J.3
Hyde, C.4
Alderson, P.5
Brunskill, S.6
-
5
-
-
50249119276
-
Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major
-
Dec 22; [Epub ahead of print]
-
Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR et al. Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major. Blood 2005 Dec 22; [Epub ahead of print]
-
(2005)
Blood
-
-
Borgna-Pignatti, C.1
Cappellini, M.D.2
De Stefano, P.3
Del Vecchio, G.C.4
Forni, G.L.5
Gamberini, M.R.6
-
6
-
-
27644547811
-
A Phase II Study with ICL670 (Exjade®), a Once-Daily Oral Iron Chelator, in Patients with Various Transfusion-Dependent Anemias and Iron Overload
-
J. Porter E. Vichinsky C. Rose A. Piga N. Olivieri N. Gattermann 2004 A Phase II Study with ICL670 (Exjade®), a Once-Daily Oral Iron Chelator, in Patients with Various Transfusion-Dependent Anemias and Iron Overload Blood 104 872A 872A
-
(2004)
Blood
, vol.104
-
-
Porter, J.1
Vichinsky, E.2
Rose, C.3
Piga, A.4
Olivieri, N.5
Gattermann, N.6
-
7
-
-
33646426524
-
A randomized, controlled phase II trial in sickle cell disease patients with chronic iron overload demonstrates that the once-daily oral iron chelator deferasirox (Exjade ((R)) ICL670) is well tolerated and reduces iron
-
E. Vichinsky R. Fischer E. Fung O. Onyekwere J. Porter P. Swerdlow 2005 A randomized, controlled phase II trial in sickle cell disease patients with chronic iron overload demonstrates that the once-daily oral iron chelator deferasirox (Exjade ((R)) ICL670) is well tolerated and reduces iron Blood 106 95A 95A
-
(2005)
Blood
, vol.106
-
-
Vichinsky, E.1
Fischer, R.2
Fung, E.3
Onyekwere, O.4
Porter, J.5
Swerdlow, P.6
-
8
-
-
1542352269
-
Phase II study of ICL670, an oral chelator, in adult thalassaemia patients with transfusional iron overload: Efficacy, safety, pharmaco kinetics (PK) and pharmacodynamics (PD) after 18 months of therapy
-
A. Piga R. Galanello M.D. Cappellini G.L. Forni G. Lupo J.M. Ford 2003 Phase II study of ICL670, an oral chelator, in adult thalassaemia patients with transfusional iron overload: Efficacy, safety, pharmaco kinetics (PK) and pharmacodynamics (PD) after 18 months of therapy Blood 102 121A 121A
-
(2003)
Blood
, vol.102
-
-
Piga, A.1
Galanello, R.2
Cappellini, M.D.3
Forni, G.L.4
Lupo, G.5
Ford, J.M.6
-
9
-
-
27744518242
-
Once-daily treatment with the oral iron chelator ICL670 (Exjade (R): Results of a phase II study in pediatric patients with beta thalassernia major
-
A. Piga R. Galanello M.L. Foschini A. Zappu E. Bordone F. Longo 2004 Once-daily treatment with the oral iron chelator ICL670 (Exjade (R): Results of a phase II study in pediatric patients with beta thalassernia major Blood 104 983A 983A
-
(2004)
Blood
, vol.104
-
-
Piga, A.1
Galanello, R.2
Foschini, M.L.3
Zappu, A.4
Bordone, E.5
Longo, F.6
-
10
-
-
33646414765
-
A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with ta-thalassemia
-
Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L et al. A Phase III study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with ta-thalassemia. Blood 2006; 107: 3455-3462.
-
(2006)
Blood
, vol.107
, pp. 3455-3462
-
-
Cappellini, M.D.1
Cohen, A.2
Piga, A.3
Bejaoui, M.4
Perrotta, S.5
Agaoglu, L.6
-
12
-
-
0037125595
-
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta thalassemia
-
L.J. Anderson B. Wonke E. Prescott S. Holden J.M. Walker D.J. Pennell 2002 Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta thalassemia Lancet 360 516 520
-
(2002)
Lancet
, vol.360
, pp. 516-520
-
-
Anderson, L.J.1
Wonke, B.2
Prescott, E.3
Holden, S.4
Walker, J.M.5
Pennell, D.J.6
-
14
-
-
12544260252
-
Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: A multicenter study by the Thalassaemia International Federation (TIF)
-
V. De Sanctis A. Eleftheriou C. Malaventura 2004 Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF) Pediatr Endocrinol Rev 2 249 255
-
(2004)
Pediatr Endocrinol Rev
, vol.2
, pp. 249-255
-
-
De Sanctis, V.1
Eleftheriou, A.2
Malaventura, C.3
-
15
-
-
0242439285
-
Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment
-
K.H. Wu F.J. Tsai C.T. Peng 2003 Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment Ann Hematol 82 540 637
-
(2003)
Ann Hematol
, vol.82
, pp. 540-637
-
-
Wu, K.H.1
Tsai, F.J.2
Peng, C.T.3
-
20
-
-
34748898486
-
Psychological problems and quality of life in children with thalassemia
-
D. Shaligram S.C. Girimaji S.K. Chaturvedi 2007 Psychological problems and quality of life in children with thalassemia Indian J Pediatr 74 727 730
-
(2007)
Indian J Pediatr
, vol.74
, pp. 727-730
-
-
Shaligram, D.1
Girimaji, S.C.2
Chaturvedi, S.K.3
-
21
-
-
0034482701
-
At term pregnancies in transfusion-dependent beta-thalassemic women
-
C. Pafumi M. Farina G. Pernicone 2000 At term pregnancies in transfusion-dependent beta-thalassemic women Clin Exp Obstet Gynecol 27 185 187
-
(2000)
Clin Exp Obstet Gynecol
, vol.27
, pp. 185-187
-
-
Pafumi, C.1
Farina, M.2
Pernicone, G.3
-
23
-
-
0032437614
-
Fertility in thalassemia: The Greek experience
-
Suppl3
-
M. Karagiorga-Lagana 1998 Fertility in thalassemia: the Greek experience J Pediatr Endocrinol Metab 11 Suppl3 945 951
-
(1998)
J Pediatr Endocrinol Metab
, vol.11
, pp. 945-951
-
-
Karagiorga-Lagana, M.1
-
24
-
-
50249143666
-
Successful pregnancy in thalassemia major women in the Thalassemia Clinical Research Network
-
M.J. Cunningham E.A. Macklin G. Muraca E.J. Neufeld 2004 Successful pregnancy in thalassemia major women in the Thalassemia Clinical Research Network Pediatr Res 55 294
-
(2004)
Pediatr Res
, vol.55
, pp. 294
-
-
Cunningham, M.J.1
MacKlin, E.A.2
Muraca, G.3
Neufeld, E.J.4
-
25
-
-
0033846355
-
Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload
-
R. Chatterjee M. Katz 2000 Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload Clin Endocrinol 53 33 42
-
(2000)
Clin Endocrinol
, vol.53
, pp. 33-42
-
-
Chatterjee, R.1
Katz, M.2
|